In conclusion, anti-β2GPI-targeted polymeric nanoparticles represent a stable and safe approach to preventing thrombus formation and vessel occlusion in a rat model of APS caused by patients’ antibodies. Here, APOH is linked to autoimmune polyendocrinopathy.